ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,810Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 519

$619K Total Retail Price of All Prescriptions

Rank: 13 out of 519

414 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 414 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 9,030 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 542 342 1 2
FUROSEMIDE 435 346 2 6
SIMVASTATIN 422 308 3 7
METFORMIN HCL 420 289 4 5
MELOXICAM 385 272 5 12
OMEPRAZOLE 379 274 6 3
TRAMADOL HCL 349 232 7 16
LISINOPRIL 349 225 7 4
CARVEDILOL 307 284 9 15
AMLODIPINE BESYLATE-BENAZEPRIL 295 226 10 44
ATORVASTATIN CALCIUM 273 206 11 17
KLOR-CON 10 265 214 12 88
HYDROCODONE-ACETAMINOPHEN 252 139 S3 13 1
PRAVASTATIN SODIUM 239 162 14 14
KLOR-CON M20 223 160 15 73
METOPROLOL SUCCINATE 221 185 16 18
HYDRALAZINE HCL 201 157 17 77
BENAZEPRIL HCL 197 157 18 61
LOVASTATIN 176 159 19 19
DIOVAN HCT 166 115 20 33
NEXIUM 160 94 21 25
METFORMIN HCL ER 159 138 22 58
NIFEDIPINE ER 153 124 23 111
LEVOTHYROXINE SODIUM 153 131 23 9
EXFORGE 151 103 25 123
RANITIDINE HCL 145 102 26 32
FEXOFENADINE HCL 144 123 27 182
AZITHROMYCIN 116 54 28 24
ZOLPIDEM TARTRATE 110 70 29 22
EXFORGE HCT 105 75 30 161
DIOVAN 105 71 30 36
FLUOXETINE HCL 105 49 30 91
TRIAMTERENE-HCTZ 102 53 33 49
ONGLYZA 97 80 34 158
LIPITOR 96 70 35 93
FOSINOPRIL SODIUM 96 89 35 192
GABAPENTIN 94 87 37 8
CRESTOR 93 52 38 27
LOSARTAN-HYDROCHLOROTHIAZIDE 92 70 39 66
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 43 40 13
CLONIDINE HCL 90 54 40 30
ALLOPURINOL 88 75 42 38
METOPROLOL TARTRATE 87 38 43 20
AMITRIPTYLINE HCL 85 60 R 44 53
LANTUS 82 74 45 72
PHENYTOIN SODIUM EXTENDED 80 30 46 146
HYDROCHLOROTHIAZIDE 79 53 47 11
CYCLOBENZAPRINE HCL 79 38 R 47 31
CIPROFLOXACIN HCL 78 52 49 29
POLYETHYLENE GLYCOL 3350 77 61 50 83
ZETIA 75 72 51 87
WARFARIN SODIUM 71 58 52 21
VYTORIN 63 50 53 150
JANUVIA 58 30 54 84
ALENDRONATE SODIUM 58 51 54 101
BYSTOLIC 57 25 56 113
PLAVIX 55 48 57 56
CLOPIDOGREL 54 48 58 39
POTASSIUM CHLORIDE 54 44 58 10
SINGULAIR 53 20 60 89
JANUMET 51 43 61 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.